ABT (Abbott Laboratories) Total Equity: $52,701 Mil (As of Mar. 2026)


ABT Abbott Laboratories ABT
80 GF Score
Price $90.49
GF Value $129.49
Valuation Significantly Undervalued
View Full Analysis

What is Abbott Laboratories Total Equity?

Abbott Laboratories ABT -0.04% 80 Total Equity is $52,701 Mil as of Mar. 2026. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.49 (Significantly Undervalued).

Abbott Laboratories's total equity for the quarter that ended in Mar. 2026 was $52,701 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Abbott Laboratories Total Equity Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Total Equity Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36,024.00 36,905.00 38,827.00 47,901.00 52,771.00

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49,064.00 50,829.00 51,264.00 52,771.00 52,701.00
ABT
80GF Score
Abbott Laboratories ABT
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Abbott Laboratories's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=86713-33942
=52,771

Abbott Laboratories's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=110429-57728
=52,701

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $52,701 Mil mean?
Abbott Laboratories (ABT) has a Total Equity of $52,701 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Abbott Laboratories and its competitors.
Is Abbott Laboratories' Total Equity too high?
Abbott Laboratories' current Total Equity is $52,701 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Total Equity compare to SYK and MDT?
Abbott Laboratories' Total Equity of $52,701 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Abbott Laboratories and its competitors. Abbott Laboratories's current Total Equity is $52,701 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.49, compared to a current price of $90.49 — trading 30.1% below its estimated fair value. The current Total Equity is $52,701 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Total Equity is $52,701 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of $90.49 is trading 30.1% below its estimated GF Value™ of $129.49. GuruFocus considers Abbott Laboratories to be Significantly Undervalued.

Key valuation signals for ABT:

  • Total Equity: $52,701 Mil
  • GF Value™: $129.49 vs. price of $90.49 (30.1% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for ABT

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.49
Price
$129.49
GF Value